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Biallelic Variants in TTLL5, Encoding
a Tubulin Glutamylase, Cause Retinal Dystrophy
Panagiotis I. Sergouniotis,1,2 Christina Chakarova,1 Cian Murphy,3 Mirjana Becker,4 Eva Lenassi,1,2
Gavin Arno,1 Monkol Lek,5,6 Daniel G. MacArthur,5,6 UCL-Exomes Consortium,
Shomi S. Bhattacharya,1 Anthony T. Moore,1,2 Graham E. Holder,1,2 Anthony G. Robson,1,2
Uwe Wolfrum,4 Andrew R. Webster,1,2,* and Vincent Plagnol3
In a subset of inherited retinal degenerations (including cone, cone-rod, andmacular dystrophies), cone photoreceptors aremore severely
affected than rods;ABCA4mutations are themost common cause of this heterogeneous class of disorders. To identify retinal-disease-asso-
ciated genes, we performed exome sequencing in 28 individuals with ‘‘cone-first’’ retinal disease and clinical features atypical for ABCA4
retinopathy.We then conducted a gene-based case-control association studywith an internal exomedata set as the control group.TTLL5,
encoding a tubulin glutamylase, was highlighted as the most likely disease-associated gene; 2 of 28 affected subjects harbored pre-
sumed loss-of-function variants: c.[1586_1589delAGAG];[1586_1589delAGAG], p.[Glu529Valfs*2];[Glu529Valfs*2], and c.[401delT(;)
3354G>A], p.[Leu134Argfs*45(;)Trp1118*]. We then inspected previously collected exome sequence data from individuals with related
phenotypes and found twosiblingswithhomozygousnonsensevariant c.1627G>T (p.Glu543*) inTTLL5. Subsequently,we tested apanel
of 55 probands with retinal dystrophy for TTLL5 mutations; one proband had a homozygous missense change (c.1627G>A
[p.Glu543Lys]). The retinal phenotype was highly similar in three of four families; the sibling pair had amore severe, early-onset disease.
Inhumanandmurine retinae,TTLL5 localized to thecentrioles at thebaseof the connecting cilium.TTLL5hasbeenpreviously reported to
be essential for the correct function of sperm flagella inmice and play a role in polyglutamylation of primary cilia in vitro. Notably, genes
involved in the polyglutamylation and deglutamylation of tubulin have been associated with photoreceptor degeneration in mice. The
electrophysiological and fundus autofluorescence imaging presented here should facilitate the molecular diagnosis in further families.Retinal dystrophies are a clinically and genetically diverse
group of inherited disorders that feature loss or dysfunc-
tion of photoreceptor cells as a primary or secondary
event.1 Thorough structural and functional assessment of
the retina can be performed with the use of optical coher-
ence tomography,2 fundus autofluorescence imaging,3 and
visual electrophysiology.4,5 The latter is critical to the accu-
rate diagnosis of retinal dystrophies and can reveal the
degree of associated cone and rod photoreceptor dysfunc-
tion. Disorders in which the cone photoreceptors are
more severely affected than rods include cone and cone-
rod dystrophies (central- and usually peripheral-cone
involvement) and macular dystrophies (central-cone
involvement). These disorders show clinical overlap, and
central visual loss in the first decades of life is a common
symptom. Genetic overlap is also observed; recessivemuta-
tions in ABCA4 (MIM 601691) are by far themost common
cause of both cone-rod and macular dystrophy.6,7 ABCA4
retinopathy exhibits extensive clinical heterogeneity, but
despite the range of phenotypes, the majority of affected
individuals have suggestive features on fundus examina-
tion. These include yellow-white retinal flecks and/or
sparing of retinal tissue around the optic disc (‘‘peripapil-
lary sparing’’). It is easier to detect these abnormalities on
fundus autofluorescence imaging, a noninvasive imaging
modality that uses naturally occurring fluorescence from1UCL Institute of Ophthalmology, London EC1V 9EL, UK; 2Moorfields Eye Ho
UK; 4Institute of Zoology, Focus Program Translational Neurosciences, Johann
Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 021
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cells.3
In order to gain insights into the molecular pathology of
retinal dystrophies, we recruited 28 families from the in-
herited-retinal-disease clinics at Moorfields Eye Hospital
in London (Table S1, available online). Inclusion criteria
were (1) a retinal dystrophy phenotype with early cone
photoreceptor involvement, (2) an unknown molecular
diagnosis after previous genetic screening or no previous
genetic testing, and (3) an absence of fundoscopic and
fundus autofluorescence imaging suggestive of ABCA4-
associated retinopathy. Data from a representative set of
22 of the 28 probands are presented in Figures 1A, 1B,
and S1, which show a common phenotype regarding
retinal topography on fundus autofluorescence imaging.
The study was approved by the local ethics committee,
and all investigations were conducted in accordance with
the principles of the Declaration of Helsinki; informed
consent was obtained from all study participants.
DNA samples were collected and analyzed by high-
throughput sequencing (exon capture by SureSelectXT
Human All Exon V5, Agilent; sequencing by HiSeq2000,
Illumina). To rank genes and prioritize follow-up, we
then performed a gene-based case-control association
study. This case-control approach compares the number
of rare potentially deleterious alleles between case andspital, London EC1V 2PD, UK; 3UCL Genetics Institute, LondonWC1E 6BT,
es Gutenberg University of Mainz, Mainz 55099, Germany; 5Analytic and
14, USA; 6Program in Medical and Population Genetics, Broad Institute of
y of Human Genetics. All rights reserved.
014
Figure 1. Color Fundus Photographs,
Fundus Autofluorescence Images, and
Foveal Optical Coherence Tomographs
of the Right Eyes of Subjects CD1, CD2,
CD3, and CD5
Images from subjects CD1 (aged 35
years; A), CD2 (aged 45 years; B), and
CD5 (aged 53 years; D) are highly similar.
Fundus autofluorescence imaging revealed
a high-density concentric perifoveal ring
surrounding irregular foveal autofluores-
cence in subjects CD1, CD2, and CD5;
outside this ring, normal signal was
observed (A, B, and D). In subject CD3
(aged 46 years; C), hypoautofluorescent
patches were noted in the fovea and paraf-
ovea; this was combined with irregular
autofluorescence outside the foveal re-
gion, suggesting more generalized retinal
pigment epithelial dysfunction (C). Opti-
cal coherence tomography revealed ab-
normalities consistent with photoreceptor
loss; they were either confined to the
foveal region (subjects CD1, CD2, and
CD5) or observed throughout the scan
(subject CD3). Scale bars represent 200 mm.control groups, hence making no specific assumption
about the mode of inheritance (dominant or recessive);
althoughmore powerful models could be used if the inher-
itance model were known, the lack of information moti-
vated this choice. The control samples (‘‘UCL-exomes
samples’’) were collected by a research consortium based
in the UK and, in particular, by University College London.
This consortium was designed to share raw read-level data
from multiple exome sequencing projects in order to facil-
itate case-control association studies.
Case-control comparisonusingcalls generated fromshort-
read high-throughput DNA sequencing is complicated by
the nonnegligible frequency of variant-calling inaccuracies
that result from limitations of existing technologies. This
issue is compounded by the heterogeneity of sequence-cap-
ture kits (especially for the diverseUCL-exomes collectionof
control samples) and variant calling. As an example, such a
technical issue arose forTTLL5 in the context of ourcompar-
ison with the NHLBI Exome Sequencing Project Exome
Variant Server (EVS, see below). To mitigate this problem,
we used a multisample sequence-variant-calling strategy,
including BAM file compression of redundant sequencing
reads,8 for the 28 probands and 1,750 internal control sam-
ples on the basis of the Genome Analysis Toolkit guidelines
(GATK version 2.7.4, Broad Institute).9 The variant-quality
recalibration steps recommendedby theGATKbest practices
were applied. Candidate variants were further filtered with
ANNOVAR (OpenBioinformatics)10 on the basis of putativeThe American Journal of Humaeffect on protein and/or mRNA (pre-
sumed loss-of-function, nonsynony-
mous, and splice-altering changes
were selected; Ensembl gene and tran-
script annotations were used).Gene-based p values were computed with two strategies:
a binomial test for excess of rare variants in the case group
and the more general gene-based testing procedure
Sequence Kernel Association Test (SKAT).11 In order to
use the UCL-exomes control samples, (1) we inferred
ancestry on the basis of the exome sequencing data, and
using a principal-component analysis, we excluded sam-
ples that did not cluster with the bulk of the UCL-exomes
samples, which are predominantly of European origin
(Figure 2A; 5 out of 28 case samples were also removed);
(2) we removed all samples with a history of retinal dis-
ease; and (3) when several samples were sequenced in
a family, we kept a single sample per family to obtain
unrelated control samples. After these exclusion steps,
1,465 control samples were left. For our binomial testing
approach, it has been previously highlighted that associa-
tion tests are biased when the same control cohort is
also used for defining a minor-allele-frequency (MAF)
threshold to flag candidate variants.12 To address this issue
while still taking advantage of our technically and ethni-
cally matched control samples, we divided the remaining
1,465 control samples into two subsets. The first subset
included 25% of the samples (n ¼ 366) and was used for
defining a MAF threshold; a MAF < 0.3% (i.e., no more
than two occurrences of the rare allele in 366 control sam-
ples) was utilized. The NHLBI Exome Sequencing Project
EVS was also used for filtering rare candidate variants
(with a frequency threshold of 0.1%). The second subsetn Genetics 94, 760–769, May 1, 2014 761
Figure 2. Case-Control Association Results
(A) Principal-component analysis (PCA) of an internal control cohort (‘‘UCL-exomes samples’’). PCA was estimated with 1,750 UCL-
exomes samples combined with 1,092 samples from diverse ethnic backgrounds; data from the latter were generated as part of the
1000 Genomes Project. Samples selected for the case-control analysis are located in the top right corner of the plot (which includes
the samples of European origin). Labels indicate the position of the 1000 Genomes subpopulations. Blue points indicate case samples,
and red points indicate the two samples with presumed loss-of-function variants in TTLL5.
(B) Total number of presumed loss-of-function (LOF) alleles in case and control groups (x axis) and the proportion of these alleles in the
23 retinal dystrophy samples (y axis). The area above the red line corresponds to a gene-based p value threshold of p < 104.
(C) Same as (B) but for the total number of nonsynonymous (ns) variants (including presumed LOF variants) and splice-site variants
(within 5 bp of a splice site). The red line corresponds to the p < 105 threshold.included the remaining 1,099 UCL-exomes control sam-
ples and was used directly for generating gene-based
case-control binomial-test association statistics. This split-
ting of the control data set was not relevant for the SKAT
gene-based testing.
The result of this genome-wide scan is shown in
Figure 2B (for presumed loss-of-function variants) and
Figure 2C (for nonsynonymous and splice-altering rare var-
iants). Table 1 shows the list of autosomal genes ranked on
the basis of the gene-based binomial p values that test for
an excess of presumed loss-of-function candidate variants
in case samples. Table S2 shows the larger set of nonsynon-Table 1. Top Five Most Significant Autosomal Genes: the Count of Pre
Probands with Retinal Dystrophy and Internal Control Samples
Gene Chr
Number of Presumed
Loss-of-Function Variants
in Probandsa (n ¼ 23)
Number
Loss-of-
in UCL-E
Samples
TTLL5 14 4 5
OR5AU1 14 2 0
CDH3 16 2 0
KRTAP3-3 17 2 0
FAM200B 4 2 0
Genes are ranked on the basis of the binomial p value test, which tests for equal p
groups against the alternative of an excess of the same class of variants in the case g
exomes control samples (366 unrelated samples, randomly sampled and not inclu
Exome Sequencing Project EVS (MAF < 0.1% was used). The following abbreviat
aThe 28 probands had (1) retinal dystrophy with early cone photoreceptor involve
no previous genetic testing, and (3) an absence of fundoscopic and fundus autofl
were excluded on the basis of ancestry (Figure 2A).
bThe 1,750 control samples were analyzed with the same sequence-variant-calling
basis of the exome sequencing data and using a principal-component analysis to
(which are predominantly of European origin; Figure 2A), (2) removing all sample
were left with 1,465 unrelated control samples.
762 The American Journal of Human Genetics 94, 760–769, May 1, 2ymous (including presumed loss-of-function) and splice-
altering variants. The loss-of-function analysis flagged
two hemizygous disease-causing variants in RPGR (MIM
300029), a gene previously associated with X-linked retinal
dystrophy, and one homozygous presumed loss-of-
function variant in another retinal-disease-related gene,
CDH3 (MIM 114021; Table S1).
The most significant gene-based p value was obtained
for TTLL5 (MIM 612268, RefSeq accession number
NM_015072.4), a gene encoding tubulin tyrosine ligase-
like family,member 5 (Tables 1 and S2). Two of 28 probands
were found to harbor a pair of presumed loss-of-functionsumed Loss-of-Function Rare Variants Was Compared between
of Presumed
Function Variants
xomes Control
b (n ¼ 1,465) SKAT p Value Binomial p Value
8.51 3 104 2.05 3 105
0.0033 4.21 3 104
0.0031 4.21 3 104
0.0034 4.21 3 104
0.0033 4.21 3 104
roportion of presumed loss-of-function rare variants between case and control
roup. To define ‘‘rare’’ variants, we utilized two cohorts: a subset of 25% of UCL-
ded directly in the case-control analysis; MAF < 0.3% was used) and the NHLBI
ion is used: Chr, chromosome.
ment, (2) an unknown molecular diagnosis after previous genetic screening or
uorescence imaging suggestive of ABCA4 retinopathy. Five of these 28 subjects
strategy as the 28 retinal dystrophy probands. After (1) inferring ancestry on the
exclude samples that did not cluster with the bulk of the UCL-exomes samples
s with a history of retinal disease, and (3) excluding related control samples, we
014
Figure 3. Pedigrees from Families
Affected by TTLL5-Related Retinal Disease
The probands are subject CD1 (IV1, family
gc1872;p.[Glu529Valfs*2];[Glu529Valfs*2]),
subject CD2 (IV:6, family gc19552;
p.[Leu134Argfs*45(;)Trp1118*]), subject
CD3 (III:4, family gc16138; p.[Glu543*];
[Glu543*]), and subject CD5 (II:1, fam-
ily gc19420; p.[Glu543Lys];[Glu543Lys]).
Interestingly, heterozygous variants were
detected in subject CD2 despite his being
born to consanguineous parents.variants in this gene. Subject CD1 (IV1, family gc18728
in Figure 3), a 38-year-old man born to consanguineous
parents, had a homozygous 4 bp deletion (c.1586_
1589delAGAG [p.Glu529Valfs*2]). Furthermore, subject
CD2 (IV:6, family gc19552 in Figure 3), a 45-year-old
male with a very similar phenotype (Figures 1A and 1B;
Table 2), had a 1 bp deletion and a nonsense mutation
each in the heterozygous state (c.[401delT(;)3354G>A],
p.[Leu134Argfs*45(;)Trp1118*]).
In addition to data from this cohort of 28 affected sub-
jects with homogeneous clinical presentation, exome
sequencing data from 63 molecularly unsolved families
with retinal dystrophies were generated as part of an
ongoing project at Moorfields Eye Hospital. The clinical di-
agnoses in these families were cone-rod dystrophy (n ¼ 4),
cone dystrophy (n ¼ 3), macular dystrophy (n ¼ 20), rod-
cone dystrophy (n ¼ 8 nonsyndromic and 11 syndromic),
early-onset retinal dystrophy (n ¼ 9), and Leber congenital
amaurosis (n¼ 8).We reviewed the exome sequencing data
from these families with the aim of identifying additional
individuals with most likely disease-causing variants in
TTLL5; a 44-year-old man (subject CD3; III:4, family
gc16138 in Figure 3) with an early-onset cone-rod dystro-
phy phenotype (Figure 1C; Table 2) was found to harbor a
homozygous nonsense variant (c.[1627G>T];[1627G>T],
p.[Glu543*];[Glu543*]). Notably, he was born to consan-
guineous parents and has an older affected brother (subject
CD4; III:1, family gc16138 in Figure 3) with the same geno-
type (Table S3). An unaffected sibling was heterozygous for
the mutation.The American Journal of HumaSubsequently, 55 additional pro-
bands with ‘‘cone-first’’ retinal dys-
trophy were ascertained and tested
for mutations in TTLL5 by Sanger
sequencing of the coding region
and intron-exon boundaries of the
gene (primers and conditions are
provided in Table S4). A 53-year-old
man (subject CD5; II:1, family
gc19420 in Figure 3) with an adult-
onset cone dystrophy phenotype
had a homozygous missense change
(c.1627G>A [p.Glu543Lys]); this
sequence alteration affects the sameamino acid that is altered in the sibling pair of subjects
CD3 and CD4.
Overall, four families affected by retinal dystrophy
and most likely disease-causing variants in TTLL5
were identified. Two frameshift (p.Leu134Argfs*45
and p.Glu529Valfs*2), two nonsense (p.Glu543* and
p.Trp1118*), and one missense (p.Glu543Lys) change
altering an amino acid conserved in all vertebrates
(Figure S2) were found. In contrast, only five presumed
loss-of-function variants were present in 1,465 unrelated
UCL-exomes control samples (Table S5). In order to esti-
mate the prevalence of disease caused by biallelic TTLL5
variants, we investigated the frequency of presumed loss-
of-function alleles in a larger data set of 26,000 exomes
assembled from a variety of complex-disease-sequencing
consortia at the Broad Institute of Harvard and MIT in
Boston. The Broad 26K exome data set includes the widely
used NHLBI Exome Sequencing Project EVS but was
reanalyzed with an optimized joint calling strategy similar
to the one applied to UCL-exomes.9 Interestingly, two
relatively common frameshift indels (up to 0.5% allele
frequency) are listed in the NHLBI EVS. Excess of homo-
zygous calls for these variants points to false-positive calls,
and indeed, the optimized multisample calling approach
excluded these calls as artifacts. Overall, the estimated
frequency of presumed loss-of-function variants in the
26,000 exomes of the Broad 26K data set was 0.09%
(Table S5), a number not statistically different (p > 0.05)
from the frequency estimate in the smaller UCL-exomes
control cohort (0.17%).n Genetics 94, 760–769, May 1, 2014 763
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764 The American Journal of Human Genetics 94, 760–769, May 1, 2The clinical and electrophysiological phenotype in three
of four families affected byTTLL5-related diseasewas almost
identical: subjects CD1, CD2, and CD5 had central and pe-
ripheral cone dysfunctionwith preservation of rod photore-
ceptor function on electrophysiology (Figure 4; Table 2)
and a similar appearance on fundus autofluorescence
imaging (Figures 1A, 1B, and 1D). In contrast, the sibling
pair of subjects CD3 and CD4 had amore severe phenotype
with poor vision from the first years of life, severe general-
ized cone-system dysfunction, and additional significant
involvement of rod photoreceptors (Figures 1C and 4;
Table 2). This clinical heterogeneity cannot be easily ex-
plained by the TTLL5 genotype; notably, subject CD1 had
presumed loss-of-function variants earlier in the protein
than did subjects CD3 and CD4 (p.[Glu529Valfs*2];
[Glu529Valfs*2]) and p.[Glu543*];[Glu543*], respectively).
TTLL5 is a 32-exon gene with high expression in heart
and skeletal muscle and lower expression in many other
tissues, including the eye (Unigene) and brain.13,14 It en-
codes a 1,281 amino acid protein that is localized to the
cytoplasm and nucleus.13 This protein is the largest of 13
members of the tubulin tyrosine ligase-like (TTLL) super-
family and contains the highly homologous core tubulin
tyrosine ligase domain in its N terminus. In addition,
TTLL5 has a C-terminal coactivator-interaction domain
and three C-terminal receptor-interaction domains.15,16
Multiple activities have been implicated for TTLL5. First,
it is thought to play an important role in the polygluta-
mylation of primary cilia.17,18 Polyglutamylation is a
posttranslation modification associated with sequential
attachment of glutamic acids (up to 20 units) to an internal
glutamate residue of the target protein.19,20 The main
target of polyglutamylation is thought to be the gluta-
mate-rich C terminus of tubulins (building blocks of mi-
crotubules),21 and TTLL5 is thought to be a key initiator
of polyglutamylation in a-tubulin.17 Second, TTLL5 has
been found to be essential for the correct function of
sperm flagella.16 Mutant mice that retain the TTLL domain
but lack the C-terminal extension that is thought to
be responsible for a variety of transcriptional cofactor
activities (including glucocortocoid-mediated gene induc-
tion)13,22 have been previously generated.16 These mice
(Stamptm/tm), despite having either no TTLL5 or markedly
reduced levels of a prematurely terminated protein
(roughly half TTLL5 will be missing), only demonstrate a
sex-dependent effect on fertility. Female mice are normal,
whereas male mice are infertile and have defective sperm
structure and motility.16 Third and finally, a recent study
has shown that TTLL5 has no unique function for ciliary
stability or beating in brain ependymal cilia.14
The tubulin tyrosine ligase domain in human TTLL5 is
predicted to be between amino acids 62 and 407 (UniProt).
It has been shown in other TTLLs that added sequences
of 100–150 amino acids on either side of the core tubulin
tyrosine ligase domain are required for full polyglu-
tamylation activity.23 Thus, it can be speculated that
four (p.Leu134Argfs*45, p.Glu529Valfs*2, p.Glu543*, and014
Figure 4. Electroretinography in TTLL5-Associated Retinal Disease
Full-field electroretinograms (ERGs) and pattern ERGs (PERGs) from subjects CD1 (aged 35 years; row 1), CD2 (aged 39 years; row 2), CD3
(aged 39 years; row 3), and CD5 (aged 53 years; row 4). Representative normal traces are shown for comparison (row 5). Dark-adapted
(DA) responses are shown for flash strengths of 0.01 cd.s/m2 (DA 0.01) and 11.0 cd.s/m2 (DA 11.0). Light-adapted (LA) ERGs are shown
for flash strength 3.0 cd.s/m2 (LA 3.0 30 Hz and LA 3.0 2 Hz). The pattern ERGs assessed macular function. Broken lines replace blink
artifacts that occurred after ERGs had attained maximum amplitudes. All responses show a high degree of interocular symmetry and are
for one eye only. See the main text and Table 2 for further explanation.p.Glu543Lys) of the five most likely disease-causing
changes identified here might result in reduced levels
of polyglutamylation. Subjects CD1 (p.[Glu529Valfs*2];
[Glu529Valfs*2]) and CD3 and CD4 (p.[Glu543*];[Glu543*])
would be expected to have a molecular defect similar to
that of the Stamptm/tm mice. It is therefore of interest that
subject CD3 has two unaffected children (Figure 3; pater-
nity has not been confirmed). Analysis of the sperm from
affected individuals might provide further insights.
It is not clear how defects in TTLL5 can cause central-
and peripheral-cone dysfunction. It has been previouslyThe Amreported that defects in fleer, a regulator of tubulin gluta-
mylation and glycylation of cilia microtubules, result
in photoreceptor outer-segment defects in zebrafish.24,25
Furthermore,mice lacking one of the enzymes that catalyze
deglutamylation of a-tubulin (Agtpbp1pcd mutant mice), an
essential subunit of cilia microtubules, have been shown
to have retinal degeneration.26,27 Interestingly, around
25% of previously reported retinal-dystrophy-related genes
are associated with the structure or function of the
photoreceptor connecting cilium, a specialized nonmotile
primary sensory cilium that represents the light-sensitiveerican Journal of Human Genetics 94, 760–769, May 1, 2014 765
Figure 5. TTLL5 Localization to the
Ciliary Base of Photoreceptor Cells
(A) Mouse retina cryosections were stained
for TTLL5 (green; Abnova) and counter-
stained for the ciliary marker centrin-3
(CEN3, red) and DAPI (blue) for nuclear
stain of the outer nuclear layer (ONL)
and inner nuclear layer (INL). The merged
image reveals substantial colocalization of
TTLL5 and CEN3 in the ciliary region of
photoreceptor cells (arrow). Double arrows
indicate cone photoreceptor cells located
in the lower portion of the photoreceptor
layer. Other abbreviations are as follows:
DIC, differential interference contrast mi-
croscopy; OS, outer segment; IS, inner
segment; OPL, outer plexiform layer; and
IPL, inner plexiform layer.
(B and C) Higher magnification of double
labeling of TTLL5 (green) and CEN3 (red)
in the photoreceptor layer of the mouse
retina demonstrated TTLL5 localization
in the periciliary region at the proximal
poles of the adjacent daughter centriole
(Ce) and the basal body (BB, mother
centriole) of the connecting cilium (CC)
of rod photoreceptor cells.
(D) Human retina cryosections through
the photoreceptor layer were stained for
TTLL5 (green) and counterstained for
CEN3 (red). Double arrows indicate cone
photoreceptor cells located in the lower
portion of the photoreceptor layer.
(E) Higher magnification of double label-
ing of TTLL5 (green) and CEN3 (red) in
the ciliary region of human photoreceptor
cells revealed a nearly identical staining
pattern.
(F) Schematic illustration of the localiza-
tion of CEN3 (red) and TTLL5 (green) in
the ciliary compartment of mouse and
human photoreceptor cells. In addition
to localizing to ciliary centrioles, TTLL5
was found at the centrioles of centrosomes
in other retinal cell types (arrowheads).
(G) Cryosections through the basal
portion of human photoreceptor layer
were triple labeled for TTLL5 (green),
CEN3 (red), and fluorescein-tagged peanut
agglutinin (PNA, Sigma Aldrich; magenta),
a molecular marker for the specialized extracellular sheath of cone photoreceptor cells. TTLL5 labeling was concentrated in cones (dou-
ble arrow). The coefficients for double staining of PNA and TTLL5 were calculated by application of the ImageJ plugin JACoP; Pearson’s
coefficient was r ¼ 0.862, and Manders’s coefficients were M1 ¼ 0.825 and M2 ¼ 0.717. These indicate colocalization of both signals.
Scale bars represent 10 mm (A), 5 mm (B and D), 1 mm (C and E), and 2.5 mm (G).outer segments.1,28 Additionally, although polyglutamyla-
tionwas initially considered a tubulin-specificmodification,
it is now well recognized as a much more widespread post-
translational modification.17 Further experiments using
proteomic approaches might demonstrate new substrates
for polyglutamylation in the retina.
To study the localization of TTLL5 in the retina, we
stained a donor human retina from a 56-year-old healthy
individual (from the Department of Ophthalmology, Uni-
versity of Mainz [Germany]) and cryofixed BI6 mouse eye
sections with TTLL5 antibodies as previously described.29
TTLL5 was detected in rod and cone photoreceptors of766 The American Journal of Human Genetics 94, 760–769, May 1, 2mouse and human retinae; in the human retina, TTLL5
staining was more prominent in cones (Figure 5). Further-
more, TTLL5 localized to the base of the connecting cilium
between the basal body (mother centriole) and the
adjacent daughter centriole of the cilium. There, TTLL5
might be responsible for the tubulin polyglutamination
in the microtubule triplets of the centrioles, increasing
the centriole stability, as previously reported.30 Notably,
as in other primary cilia, the periciliary region of the
photoreceptor cilium harbors the molecular modules for
the regulation of delivery into the ciliary compartment,
namely the connecting cilium (transition zone) and the014
photosensitive outer segment.31,32 It is worthy of specula-
tion that polyglutamylation of tubulin molecules destined
for the cilium might occur in this strategic site at the base
of the cilium. In any case, the microtubules of the photo-
receptor cilia apparatus are stabilized against mechanical
forces. Given that cones are characterized by open mem-
brane disks lacking the complete sheath of the plasma
membrane present in rods, the absence of TTLL5, which
should result in the destabilization of the microtubule
cytoskeleton of photoreceptor cells, might affect the
maintenance of cones more than rods. In the periciliary
compartment, the products of other ciliopathy genes can
be found.33–37
We have shown that TTLL5, encoding a member of the
TTLL superfamily, is associated with human disease. Other
genes encoding members of the TTLL family have been
shown to cause a variety of disorders in animal models;
these include primary ciliary dyskinesia in Ttll1 mutant
mice38 and defective olfactory cilia structures in ttll6
mutant zebrafish.24,25 The human phenotype observed
in the present study would be consistent with some degree
of functional redundancy among some of these glutamy-
lating enzymes in humans.
To date, mutations in over 200 genes have been shown
to cause retinal degeneration (Retinal Information
Network, see Web Resources). The identification of genes
associated with these disorders is a major challenge, partic-
ularly because they are likely to be less prevalent and less
obvious candidates than those already known. We have
performed exome sequencing in 28 individuals with a
similar disease phenotype and subsequently used a case-
control approach to identify mutations in TTLL5 as a cause
of recessive retinal dystrophy. This powerful approach
facilitates the identification of disease-causing alleles
among the background of nonpathogenic genomic varia-
tion and sequencing errors. Overall, three families affected
by presumed loss-of-function variants and one proband
with a homozygous missense change were identified. The
electrophysiological and fundus autofluorescence imaging
reported in the present series should hopefully facilitate
the identification of further families.Supplemental Data
Supplemental Data include two figures and five tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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